Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study.

Nephrology (Carlton) · 2021 · PMC7754421 · PMID 32743932

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Keywords: anaemia, erythropoietin hyporesponsiveness, fibroblast growth factor 23, haemodialysis, haemoglobin SUMMARY AT A GLANCE The study included 1044 patients in Japan from J‐DOPPS and found that the lowest and highest levels of serum FGF‐23 were associated with increased odds of ESA‐hyporesponsiveness in patients on maintenance haemodialysis, though this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.